BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Apr 25, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Verigene Warfarin Metabolism Nucleic Acid Test regulatory update

Nanosphere received CE Mark approval in the EU for its Verigene Warfarin Metabolism Nucleic Acid Test as an aid in identifying patients at risk for...

Read the full 103 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >